WO2004101607A3 - Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh - Google Patents
Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh Download PDFInfo
- Publication number
- WO2004101607A3 WO2004101607A3 PCT/US2004/014932 US2004014932W WO2004101607A3 WO 2004101607 A3 WO2004101607 A3 WO 2004101607A3 US 2004014932 W US2004014932 W US 2004014932W WO 2004101607 A3 WO2004101607 A3 WO 2004101607A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cells
- methodology
- identification
- positive cells
- present
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 4
- 230000000052 comparative effect Effects 0.000 title 1
- 238000013507 mapping Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
- 238000002955 isolation Methods 0.000 abstract 2
- 238000000746 purification Methods 0.000 abstract 2
- 231100000588 tumorigenic Toxicity 0.000 abstract 2
- 230000000381 tumorigenic effect Effects 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 1
- 231100001221 nontumorigenic Toxicity 0.000 abstract 1
- 230000037452 priming Effects 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 230000008685 targeting Effects 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
- C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/21—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a His-tag
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04752061A EP1625151A2 (fr) | 2003-05-13 | 2004-05-13 | Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US46999503P | 2003-05-13 | 2003-05-13 | |
US60/469,995 | 2003-05-13 | ||
US51813203P | 2003-11-07 | 2003-11-07 | |
US60/518,132 | 2003-11-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004101607A2 WO2004101607A2 (fr) | 2004-11-25 |
WO2004101607A3 true WO2004101607A3 (fr) | 2005-08-11 |
Family
ID=33457169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2004/014932 WO2004101607A2 (fr) | 2003-05-13 | 2004-05-13 | Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh |
Country Status (2)
Country | Link |
---|---|
EP (1) | EP1625151A2 (fr) |
WO (1) | WO2004101607A2 (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090062512A1 (en) * | 2000-10-10 | 2009-03-05 | Hildebrand William H | Comparative ligand mapping from MHC class I positive cells |
WO2007030451A2 (fr) * | 2005-09-07 | 2007-03-15 | Receptor Logic, Ltd. | Anticorps utilises comme mimetiques de recepteurs de lymphocytes t, leurs methodes de production et leurs applications |
EP2740484A1 (fr) * | 2012-12-05 | 2014-06-11 | Lipotec, S.A. | Compose utiles dans le traitement et/ou les soins de la peau, des muqueuses du cuir chevelu et/ou des cheveux et leur utilisation dans des compositions cosmétiques ou pharmaceutiques |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002086122A2 (fr) * | 2001-03-14 | 2002-10-31 | Hybrigenics | Interactions proteine-proteine intensifiees dans des cellules adipeuses |
-
2004
- 2004-05-13 WO PCT/US2004/014932 patent/WO2004101607A2/fr active Application Filing
- 2004-05-13 EP EP04752061A patent/EP1625151A2/fr not_active Withdrawn
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002086122A2 (fr) * | 2001-03-14 | 2002-10-31 | Hybrigenics | Interactions proteine-proteine intensifiees dans des cellules adipeuses |
Non-Patent Citations (3)
Title |
---|
DATABASE EPO Proteins [online] 27 March 2003 (2003-03-27), "Sequence 1267 from Patent WO02086122.", XP002314962, retrieved from EBI accession no. EPOP:AX678488 Database accession no. AX678488 * |
RAMMENSEE HANS-GEORG ET AL: "SYFPEITHI: Database for MHC ligands and peptide motifs", IMMUNOGENETICS, SPRINGER VERLAG, BERLIN, DE, vol. 50, no. 3-4, November 1999 (1999-11-01), pages 213 - 219, XP002183663, ISSN: 0093-7711 * |
SATHIAMURTHY M ET AL: "Population of the HLA ligand database.", TISSUE ANTIGENS, vol. 61, no. 1, January 2003 (2003-01-01), pages 12 - 19, XP002314961, ISSN: 0001-2815 * |
Also Published As
Publication number | Publication date |
---|---|
EP1625151A2 (fr) | 2006-02-15 |
WO2004101607A2 (fr) | 2004-11-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004060308A3 (fr) | Thiosemicarbazones antiviraux et immunostimulants | |
WO2002030964A3 (fr) | Mappage comparatif de ligand a partir de cellules positives cmh | |
WO2004080403A3 (fr) | Vaccin contre le virus de la grippe | |
WO2007119011A3 (fr) | Proteines de fusion proteine n d'un virus de la famille des paramyxoviridae-proteine d'interet | |
WO2004024757A3 (fr) | Molecules pna modifiées | |
WO2008127364A3 (fr) | Composés antiviraux et utilisation de ceux-ci | |
EP2078083A4 (fr) | Nouveau virus de la grippe canine et vaccin correspondant | |
UA95715C2 (ru) | Фосфадиазиновые производные, фармацевтическая композиция и их применение | |
WO2009009759A3 (fr) | Antigènes yersinia pestis, compositions de vaccins, et méthodes associées | |
WO2007019865A3 (fr) | Traitement au moyen de peptides de liaison cd4 et par rayonnements | |
ATE458746T1 (de) | Melphalan-derivate und ihre verwendung als chemotherapeutika gegen krebs | |
WO2010041241A3 (fr) | Peptides dérivés de l'intégrase du vih-1 et compositions | |
WO2006137938A3 (fr) | Fragments d'anticorps assurant la protection contre l'infection par des pathogenes, methodes d'utilisation de ces derniers | |
WO2006113907A3 (fr) | Proteines d'escherichia coli o157:h7 et utilisations de ces proteines | |
WO2009037183A3 (fr) | Préparation cosmétique et/ou pharmaceutique contenant des acides nucléiques destinée à la production de peptides antimicrobiens dans des tissus épithéliaux | |
ATE380557T1 (de) | E. coli vakzin zur protektion von geflügel gegen colibazillose | |
WO2005023849A3 (fr) | Peptides antigeniques du virus rabique et leurs utilisations | |
CL2008001719A1 (es) | Compuestos derivados de [1,10]-fenantrolina; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades neurodegenerativas o hematologicas. | |
WO2007053644A3 (fr) | Cartographie comparative des ligands de cellules positives vis-a-vis du mhc de classe i | |
WO2004101607A3 (fr) | Representation cartographique comparative de ligands a partir de cellules positives de classe i du cmh | |
WO2009051823A3 (fr) | Chromosome bactérien artificiel contenant le génome du virus de l'herpès félin de type 1 et ses utilisations | |
DK1778271T3 (da) | Peptid til behandling af herpesvirusinfektioner | |
WO2009077744A3 (fr) | Vaccins contre la brucellose | |
WO2007076091A3 (fr) | Traitement d’infections virales utilisant un inhibiteur de facteur tissulaire | |
TW200722097A (en) | Aqueous inhalation pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004752061 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004752061 Country of ref document: EP |